China's Hansoh Pharma strikes drug deal with Roche worth over $15 billion | Reuters

Roche partners with Hansoh Pharma in deal worth over $15 billion

Roche has entered a partnership and licensing deal with China's Hansoh Pharmaceutical worth potentially more than $15 billion, covering a portfolio of antibody-drug conjugates across multiple cancer types.